{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:53:06Z","timestamp":1764784386201,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.urolonc.2019.12.013","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T02:34:21Z","timestamp":1581734061000},"page":"410-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2168-323X","authenticated-orcid":false,"given":"Juan","family":"Morote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Celma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7121-1946","authenticated-orcid":false,"given":"Lucas","family":"Regis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarai","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda E.","family":"Semidey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s M.","family":"de Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Trilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2019.12.013_bib0001","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"year":"2019","series-title":"Guidelines on prostate cancer","author":"Mottet","key":"10.1016\/j.urolonc.2019.12.013_bib0002"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0003","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bju.14361","article-title":"National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection\u2014recommendations from a UK consensus meeting","volume":"122","author":"Brizmohun Appayya","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euo.2018.09.001","article-title":"Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7-10 prostate cancer in biopsy-na\u00efve men","volume":"2","author":"Boesen","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0006","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1007\/s00330-017-4800-5","article-title":"Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer","volume":"27","author":"Wang","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0007","first-page":"618","article-title":"What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel","volume":"71","author":"Moldovan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0008","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","article-title":"Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer","volume":"147","author":"Benson","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0009","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/RCT.0b013e318296af5f","article-title":"Prostate volumetric assessment by magnetic resonance imaging and transrectal ultrasound: impact of variation in calculated prostate-specific antigen density on patient eligibility for active surveillance program","volume":"37","author":"Dianat","year":"2013","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","article-title":"The value of PSA density in combination with PI-RADS\u2122 for the accuracy of prostate cancer prediction","volume":"198","author":"Distler","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bju.13465","article-title":"Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy na\u00efve patients","volume":"119","author":"Washino","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0012","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/bju.13619","article-title":"The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting","volume":"119","author":"Hansen","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0013","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00345-018-2341-4","article-title":"The role of mpMRI and PSA density in patients with an initial negative prostatic biopsy","volume":"36","author":"Kotb","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0014","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejrad.2018.05.004","article-title":"PSA-density does not improve bi-parametric prostate MR detection of prostate cancer in a biopsy na\u00efve patient population","volume":"104","author":"Cuocolo","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0015","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging\u2014reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0017","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2014.11.037","article-title":"Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis","volume":"68","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0018","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/PAS.0000000000000208","article-title":"Proposed morphologic classification of prostate cancer with neuroendocrine differentiation","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0019","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.juro.2011.03.147","article-title":"Characterizing clinically significant prostate cancer using template prostate mapping biopsy","volume":"186","author":"Ahmed","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0020","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00261-017-1080-0","article-title":"Clinical and multiparametric MRI signatures of granulomatous prostatitis","volume":"42","author":"Rais-Bahrami","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.urology.2015.09.035","article-title":"Combined biparametric prostate magnetic resonance imaging and prostate-specific antigen in the detection of prostate cancer: a validation study in a biopsy-naive patient population","volume":"88","author":"Fascelli","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0022","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urolonc.2015.01.004","article-title":"Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results","volume":"33","author":"Abdi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0023","first-page":"656","article-title":"Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA","volume":"9","author":"Yanai","year":"2018","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0024","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.urology.2018.12.010","article-title":"Magnetic resonance imaging-defined prostate-specific antigen density significantly improves the risk prediction for clinically significant prostate cancer on biopsy","volume":"219","author":"Bhat","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.euo.2018.02.010","article-title":"Prostate cancer risk assessment in biopsy-na\u00efve patients: the Rotterdam prostate cancer risk calculator in multiparametric magnetic resonance maging-transrectal ultrasound (TRUS) fusion biopsy and systematic TRUS Biopsy","volume":"1","author":"Mannaerts","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2019.12.013_bib0026","doi-asserted-by":"crossref","first-page":"E1637","DOI":"10.3390\/ijms20071637","article-title":"Prediction medicine: biomarkers, risk calculators and magnetic resonance imaging as risk stratification tools in prostate cancer diagnosis","volume":"20","author":"Osses","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919305009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919305009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:18:19Z","timestamp":1761041899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919305009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1078143919305009"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.12.013","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}